Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries

Journal of the American Geriatrics Society

Volumn 55, Issue 10, 2007, Pages 1508-1516

  Gruber Baldini, Ann L ^a   Stuart, Bruce ^b   Zuckerman, Ilene H ^b   Simoni Wastila, Linda ^b   Miller, Ram ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Community; Dementia; Long term care; Medications; Prevalence

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DONEPEZIL; GALANTAMINE; HALOPERIDOL; NOOTROPIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; ZIPRASIDONE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; COMMUNITY LIVING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; DRUG UTILIZATION; FEMALE; HEALTH SURVEY; HUMAN; INSTITUTIONALIZATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICARE; PRESCRIPTION; PREVALENCE; SELF REPORT;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; CHOLINESTERASE INHIBITORS; DEMENTIA; FEMALE; HUMANS; INSTITUTIONALIZATION; LONG-TERM CARE; MALE; MEDICARE; MIDDLE AGED; PREVALENCE; UNITED STATES;

EID: 34848814812     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01387.x     Document Type: Article

References (31)

1. Langa KM, Foster NL, Larson EB. Mixed dementia: Emerging concepts and therapeutic implications. JAMA 2004 292 : 2901 2908.
2. Hebert LE, Scherr PA, Bienias JL et al. Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol 2003 60 : 1119 1122.
3. Office of Technology Assessment. Losing a Million Minds: Confronting the Tragedy of Alzheimer's Disease and Other Dementias (Congressional Summary). OTA-BA-324. Washington, DC : U.S. Government Printing Office, 1987.
4. Short P, Feinleib S, Cunningham P. Expenditures and Sources of Payment for Persons in Nursing and Personal Care Homes. AHCPR Pub No. 94-0032. Rockville, MD : Agency for Health Care Policy and Research, 1994.
5. Magaziner J, German P, Zimmerman SI et al. The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: Diagnosis by expert panel. Gerontologist 2000 40 : 663 672.
6. Eaker ED, Vierkant RA, Mickel SF. Predictors of nursing home admission and/or death in incident Alzheimer's disease and other dementia cases compared to controls: A population-based study. J Clin Epidemiol 2002 55 : 462 468.
7. Welch HG, Walsh JS, Larson EB. The cost of institutional care in Alzheimer's disease: Nursing home and hospital use in a prospective cohort. J Am Geriatr Soc 1992 40 : 221 224.
8. Erkinjuntti T, Ostbye T, Steenhuis R et al. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997 337 : 1667 1674.
9. Forchetti CM. Treating patients with moderate to severe Alzheimer's disease: Implications of recent pharmacologic studies. Prim Care Companion J Clin Psychiatry 2005 7 : 155 161.
10. Tariot PN, Farlwo MR, Grossberg GT et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: A randomized controlled trial. JAMA 2004 291 : 317 324.
11. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence. JAMA 2005 293 : 596 608.
12. Langa KM, Plassman BL, Wallace RB et al. The Aging, Demographics, and Memory Study: Study design and methods. Neuroepidemiology 2005 25 : 181 191.
13. Gruber-Baldini A, Zuckerman I, Du D et al. Literature Review of Dementia Treatments. Report to AHRQ DEcIDE (Developing Evidence to Inform Decisions and Effectiveness) Network. February 2006.
14. Carlson JM, Gerding G, Estoup MW. Evaluation of demographics and medication use in patients with dementia in assisted living and skilled nursing facilities. Consult Pharm 2005 20 : 584 594.
15. Magsi H, Malloy T. Underrecognition of cognitive impairment in assisted living facilities. J Am Geriatr Soc 2005 53 : 295 298.
16. Rosenblatt A, Samus QM, Steele CD et al. The Maryland Assisted Living Study: Prevalence, recognition, and treatment of dementia and other psychiatric disorders in the assisted living population of central Maryland. J Am Geriatr Soc 2004 52 : 1618 1625.
17. U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services. Codebooks, 2002 Cost and Use [on-line]. Available at Accessed July 17, 2007.
18. Gruber-Baldini AL, Zimmerman SI, Mortimore E et al. The validity of the minimum data set in measuring the cognitive impairment of persons admitted to nursing homes. J Am Geriatr Soc 2000 48 : 1601 1606.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977 33 : 159 174.
20. Alzheimer's Association. Chronic Conditions Report [on-line]. Available at Accessed July 17, 2007.
21. American Health Care Association. Medical Condition-Mental Status-CMS OSCAR Data Current Surveys, December 2005 [on-line]. Available at Accessed October 18, 2006.
22. Alzheimer's Association. Facts and Figures [on-line]. Available at Accessed July 17, 2007.
23. Newcomer R, Clay T, Luxenberg JS et al. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. J Am Geriatr Soc 1999 47 : 215 219.
24. Taylor DHJ, Fillenbaum GG, Ezell ME. The accuracy of medicare claims data in identifying Alzheimer's disease. J Clin Epidemiol 2002 55 : 929 937.
25. Feldman H, Gauthier S, Hecker J et al. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology 2001 57 : 613 620.
26. Gasper MC, Ott BR, Lapane KL. Is donepezil therapy associated with reduced mortality in nursing home residents with dementia? Am Geriatr Pharmacother 2005 3 : 1 7.
27. Eisai Co. Ltd. Eisai Reports Results from Latest Donepezil Study in Vascular Dementia [on-line]. March 16, 2006. Available at Accessed July 17, 2007.
28. Pedone C, Lapane KL, Mor V et al. Donepezil use in US nursing homes. Aging Clin Exp Res 2004 16 : 60 67.
29. Briesacher B, Limcangco R, Simoni-Wastila L et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 2005 165 : 1280 1285.
30. Martin BC, Ricci JF, Kotzan JA et al. The net cost of Alzheimer disease and related dementia: A population-based study of Georgia Medicaid recipients. Alzheimer Dis Assoc Disord 2000 14 : 151 159.
31. Menzin J, Lang K, Friedman M et al. The economic cost of Alzheimer's disease and related dementias to the California Medicaid program ("Medi-Cal") in 1995. Am J Geriatr Psychiatry 1999 7 : 300 308.